HEADER LIGASE 20-MAR-15 4UFZ TITLE SYNTHESIS OF NOVEL NAD DEPENDANT DNA LIGASE INHIBITORS VIA NEGISHI TITLE 2 CROSS-COUPLING: DEVELOPMENT OF SAR AND RESISTANCE STUDIES COMPND MOL_ID: 1; COMPND 2 MOLECULE: DNA LIGASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: ADENYLATION DOMAIN, RESIDUES 1-324; COMPND 5 SYNONYM: POLYDEOXYRIBONUCLEOTIDE SYNTHASE NAD(+), NAD DEPENDENT DNA COMPND 6 LIGASE; COMPND 7 EC: 6.5.1.2; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HAEMOPHILUS INFLUENZAE; SOURCE 3 ORGANISM_TAXID: 727; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS LIGASE EXPDTA X-RAY DIFFRACTION AUTHOR K.E.MURPHY-BENENATO,P.A.BORIACK-SJODIN,G.MARTINEZ-BOTELLA, AUTHOR 2 D.CARCANAGUE,L.GINGIPALI,M.GOWRAVARAM,J.HARANG,M.HALE,G.IOANNIDIS, AUTHOR 3 H.JAHIC,M.JOHNSTONE,A.KUTSCHKE,V.A.LAGANAS,J.LOCH,H.OGUTO,S.J.PATEL REVDAT 3 04-APR-18 4UFZ 1 REMARK REVDAT 2 11-NOV-15 4UFZ 1 JRNL REVDAT 1 28-OCT-15 4UFZ 0 JRNL AUTH K.E.MURPHY-BENENATO,L.GINGIPALLI,P.A.BORIACK-SJODIN, JRNL AUTH 2 G.MARTINEZ-BOTELLA,D.CARCANAGUE,C.J.EYERMANN,M.GOWRAVARAM, JRNL AUTH 3 J.HARANG,M.R.HALE,G.IOANNIDIS,H.JAHIC,M.JOHNSTONE, JRNL AUTH 4 A.KUTSCHKE,V.A.LAGANAS,J.T.LOCH,M.D.MILLER,H.OGUTO,S.J.PATEL JRNL TITL NEGISHI CROSS-COUPLING ENABLED SYNTHESIS OF NOVEL JRNL TITL 2 NAD(+)-DEPENDENT DNA LIGASE INHIBITORS AND SAR DEVELOPMENT. JRNL REF BIOORG.MED.CHEM.LETT. V. 25 5172 2015 JRNL REFN ISSN 0960-894X JRNL PMID 26463129 JRNL DOI 10.1016/J.BMCL.2015.09.075 REMARK 2 REMARK 2 RESOLUTION. 2.33 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.33 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.88 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.7 REMARK 3 NUMBER OF REFLECTIONS : 23234 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.222 REMARK 3 R VALUE (WORKING SET) : 0.221 REMARK 3 FREE R VALUE : 0.250 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.140 REMARK 3 FREE R VALUE TEST SET COUNT : 1195 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 12 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.33 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.43 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.65 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2630 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2574 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2489 REMARK 3 BIN R VALUE (WORKING SET) : 0.2530 REMARK 3 BIN FREE R VALUE : 0.3375 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.36 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 141 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2510 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 42 REMARK 3 SOLVENT ATOMS : 157 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 53.59 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.53 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.34900 REMARK 3 B22 (A**2) : 0.34900 REMARK 3 B33 (A**2) : -0.69800 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.337 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.248 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.202 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.571 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.201 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.933 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.913 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 5147 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 9304 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1129 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 72 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 774 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 5147 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : 1 ; 5.000 ; SEMIHARMONIC REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 338 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5509 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.00 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.41 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 14.33 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4UFZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 20-MAR-15. REMARK 100 THE DEPOSITION ID IS D_1290063409. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-MAR-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : OSMICS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : D*TREK REMARK 200 DATA SCALING SOFTWARE : DTSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23253 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.330 REMARK 200 RESOLUTION RANGE LOW (A) : 31.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.7 REMARK 200 DATA REDUNDANCY : 4.380 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 2.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.33 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.41 REMARK 200 COMPLETENESS FOR SHELL (%) : 91.1 REMARK 200 DATA REDUNDANCY IN SHELL : 3.18 REMARK 200 R MERGE FOR SHELL (I) : 0.32000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 0.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NONE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 66.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.70 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 28.08250 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 69.40700 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 69.40700 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 42.12375 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 69.40700 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 69.40700 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 14.04125 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 69.40700 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 69.40700 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 42.12375 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 69.40700 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 69.40700 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 14.04125 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 28.08250 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 318 REMARK 465 GLN A 319 REMARK 465 GLU A 320 REMARK 465 GLU A 321 REMARK 465 LEU A 322 REMARK 465 THR A 323 REMARK 465 LEU A 324 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 96 CG CD CE NZ REMARK 470 LYS A 107 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 27 68.05 -155.46 REMARK 500 ASP A 118 72.12 -101.58 REMARK 500 ASN A 193 48.71 39.75 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IA7 A 1318 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IWH A 1319 DBREF 4UFZ A 1 324 UNP P43813 DNLJ_HAEIN 1 324 SEQRES 1 A 324 MET THR ASN ILE GLN THR GLN LEU ASP ASN LEU ARG LYS SEQRES 2 A 324 THR LEU ARG GLN TYR GLU TYR GLU TYR HIS VAL LEU ASP SEQRES 3 A 324 ASN PRO SER VAL PRO ASP SER GLU TYR ASP ARG LEU PHE SEQRES 4 A 324 HIS GLN LEU LYS ALA LEU GLU LEU GLU HIS PRO GLU PHE SEQRES 5 A 324 LEU THR SER ASP SER PRO THR GLN ARG VAL GLY ALA LYS SEQRES 6 A 324 PRO LEU SER GLY PHE SER GLN ILE ARG HIS GLU ILE PRO SEQRES 7 A 324 MET LEU SER LEU ASP ASN ALA PHE SER ASP ALA GLU PHE SEQRES 8 A 324 ASN ALA PHE VAL LYS ARG ILE GLU ASP ARG LEU ILE LEU SEQRES 9 A 324 LEU PRO LYS PRO LEU THR PHE CYS CYS GLU PRO LYS LEU SEQRES 10 A 324 ASP GLY LEU ALA VAL SER ILE LEU TYR VAL ASN GLY GLU SEQRES 11 A 324 LEU THR GLN ALA ALA THR ARG GLY ASP GLY THR THR GLY SEQRES 12 A 324 GLU ASP ILE THR ALA ASN ILE ARG THR ILE ARG ASN VAL SEQRES 13 A 324 PRO LEU GLN LEU LEU THR ASP ASN PRO PRO ALA ARG LEU SEQRES 14 A 324 GLU VAL ARG GLY GLU VAL PHE MET PRO HIS ALA GLY PHE SEQRES 15 A 324 GLU ARG LEU ASN LYS TYR ALA LEU GLU HIS ASN GLU LYS SEQRES 16 A 324 THR PHE ALA ASN PRO ARG ASN ALA ALA ALA GLY SER LEU SEQRES 17 A 324 ARG GLN LEU ASP PRO ASN ILE THR SER LYS ARG PRO LEU SEQRES 18 A 324 VAL LEU ASN ALA TYR GLY ILE GLY ILE ALA GLU GLY VAL SEQRES 19 A 324 ASP LEU PRO THR THR HIS TYR ALA ARG LEU GLN TRP LEU SEQRES 20 A 324 LYS SER ILE GLY ILE PRO VAL ASN PRO GLU ILE ARG LEU SEQRES 21 A 324 CYS ASN GLY ALA ASP GLU VAL LEU GLY PHE TYR ARG ASP SEQRES 22 A 324 ILE GLN ASN LYS ARG SER SER LEU GLY TYR ASP ILE ASP SEQRES 23 A 324 GLY THR VAL LEU LYS ILE ASN ASP ILE ALA LEU GLN ASN SEQRES 24 A 324 GLU LEU GLY PHE ILE SER LYS ALA PRO ARG TRP ALA ILE SEQRES 25 A 324 ALA TYR LYS PHE PRO ALA GLN GLU GLU LEU THR LEU HET IA7 A1318 23 HET IWH A1319 19 HETNAM IA7 5,7-BIS(AZANYL)-2-TERT-BUTYL-4-(1,3-THIAZOL-2-YL) HETNAM 2 IA7 PYRIDO[2,3-D]PYRIMIDINE-6-CARBONITRILE HETNAM IWH 1-(2,4-DIMETHYLBENZYL)-6-OXO-1,6-DIHYDROPYRIDINE-3- HETNAM 2 IWH CARBOXAMIDE FORMUL 2 IA7 C15 H15 N7 S FORMUL 3 IWH C15 H16 N2 O2 FORMUL 4 HOH *157(H2 O) HELIX 1 1 THR A 2 VAL A 24 1 23 HELIX 2 2 PRO A 31 HIS A 49 1 19 HELIX 3 3 PRO A 50 LEU A 53 5 4 HELIX 4 4 SER A 87 LEU A 102 1 16 HELIX 5 5 ILE A 146 THR A 152 1 7 HELIX 6 6 PRO A 178 HIS A 192 1 15 HELIX 7 7 ASN A 199 ARG A 209 1 11 HELIX 8 8 ASP A 212 LYS A 218 1 7 HELIX 9 9 THR A 239 ILE A 250 1 12 HELIX 10 10 GLY A 263 ARG A 278 1 16 HELIX 11 11 SER A 279 LEU A 281 5 3 HELIX 12 12 ASP A 294 GLY A 302 1 9 SHEET 1 AA 2 GLN A 72 ARG A 74 0 SHEET 2 AA 2 THR A 142 GLU A 144 -1 O GLY A 143 N ILE A 73 SHEET 1 AB 3 ARG A 259 ASN A 262 0 SHEET 2 AB 3 THR A 110 LEU A 117 -1 O PHE A 111 N CYS A 261 SHEET 3 AB 3 ILE A 285 ILE A 292 -1 N ASP A 286 O LYS A 116 SHEET 1 AC 4 GLU A 130 THR A 136 0 SHEET 2 AC 4 LEU A 120 VAL A 127 -1 O SER A 123 N ALA A 135 SHEET 3 AC 4 ARG A 168 PHE A 176 -1 O LEU A 169 N TYR A 126 SHEET 4 AC 4 VAL A 222 GLU A 232 -1 O VAL A 222 N PHE A 176 CISPEP 1 LYS A 107 PRO A 108 0 9.79 SITE 1 AC1 12 LEU A 80 SER A 81 LEU A 82 GLU A 114 SITE 2 AC1 12 LYS A 116 LEU A 117 ALA A 121 ARG A 137 SITE 3 AC1 12 GLU A 174 TYR A 226 VAL A 289 LYS A 291 SITE 1 AC2 11 TYR A 18 GLU A 21 TYR A 22 HIS A 23 SITE 2 AC2 11 ASN A 27 VAL A 30 PRO A 31 ASP A 32 SITE 3 AC2 11 TYR A 35 HOH A2022 HOH A2028 CRYST1 138.814 138.814 56.165 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007204 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007204 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017805 0.00000